Regulatory T-cells in Psoriasis Patients as Targets for Therapy
NCT01233583
·
clinicaltrials.gov ↗
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Dovobet, neotigason, etanercept, adalimumab. infliximab
Sponsor
University of Aberdeen
Collaborators
[object Object]